Addressing Biomedical Science’s PhD Problem

Researchers and institutions seek to bridge the gap between emerging life science professionals and available positions.

| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

© iSTOCK.COM/THEADESIGNPhD degrees aren’t what they used to be. In 1973, more than half of doctoral degree graduates in biological sciences landed a tenure-track position within six years. Three decades later, that fraction had dropped to 15 percent. Demand has not kept pace with supply, says Bruce Alberts, a professor of biochemistry at the University of California, San Francisco (UCSF), and cofounder of the nonprofit organization Rescuing Biomedical Research (RBR). “The real world for [biomedical PhD students] is that maybe a fifth will ever get academic jobs,” he says. And it’s not just academia that’s overpopulated, he adds. “There aren’t even enough jobs currently in the private sector to make it possible for all of them to get research jobs.”

As a result, trainees spend more and more time in postdoctoral positions, and even then, their chances of landing a tenure-track position are in decline. Several years of survey data collected by the American Association for the Advancement of Science (AAAS) show that, although the percentage of postdocs expecting to land a tenure-track faculty position stayed above 50 percent from 2010 to 2012, the percentage who actually do so fell from 37 percent to 21 percent. Unemployment following a postdoc position, meanwhile, rose from 2 percent to 10 percent over the same time period.

Yet despite these sobering statistics, PhD programs continue to grow—in the U.S., the life sciences saw an increase from around 8,000 doctoral recipients in 2004 to more than 12,500 a decade ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Catherine Offord

    Catherine is a science journalist based in Barcelona.

Published In

January 2017

Driving Out Disease

Scenarios for the genetic manipulation of mosquito vectors

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours